Liquidia Corp. (LQDA)
58.12
+2.91
(+5.27%)
USD |
NASDAQ |
Nov 12, 16:00
57.73
-0.39
(-0.67%)
After-Hours: 06:50
Liquidia Enterprise Value : 4.988B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.988B |
| November 11, 2026 | 4.727B |
| November 10, 2026 | 4.385B |
| November 09, 2026 | 4.068B |
| November 06, 2026 | 3.757B |
| November 05, 2026 | 3.765B |
| November 04, 2026 | 4.024B |
| November 03, 2026 | 3.559B |
| November 02, 2026 | 3.528B |
| October 30, 2026 | 3.816B |
| October 29, 2026 | 3.810B |
| October 28, 2026 | 3.875B |
| October 27, 2026 | 3.850B |
| October 26, 2026 | 3.697B |
| October 23, 2026 | 3.600B |
| October 22, 2026 | 3.334B |
| October 21, 2026 | 3.260B |
| October 20, 2026 | 3.034B |
| October 19, 2026 | 2.835B |
| October 16, 2026 | 2.855B |
| October 15, 2026 | 2.893B |
| October 14, 2026 | 2.818B |
| October 13, 2026 | 2.178B |
| October 12, 2026 | 2.256B |
| October 09, 2026 | 2.229B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.287B |
| October 07, 2026 | 2.167B |
| October 06, 2026 | 2.098B |
| October 05, 2026 | 2.253B |
| October 02, 2026 | 2.343B |
| October 01, 2026 | 2.284B |
| September 30, 2026 | 2.488B |
| September 29, 2026 | 6.197B |
| September 28, 2026 | 6.463B |
| September 25, 2026 | 5.996B |
| September 24, 2026 | 6.220B |
| September 23, 2026 | 5.912B |
| September 22, 2026 | 6.015B |
| September 21, 2026 | 5.818B |
| September 18, 2026 | 5.858B |
| September 17, 2026 | 5.992B |
| September 16, 2026 | 5.998B |
| September 15, 2026 | 5.754B |
| September 14, 2026 | 5.717B |
| September 11, 2026 | 5.845B |
| September 10, 2026 | 5.944B |
| September 09, 2026 | 6.057B |
| September 08, 2026 | 5.929B |
| September 04, 2026 | 6.016B |
| September 03, 2026 | 6.014B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| United Therapeutics Corp. | 23.08B |
| Johnson & Johnson | 709.89B |
| Eli Lilly & Co. | 1.388T |
| Pfizer Inc. | 213.03B |
| Amneal Pharmaceuticals, Inc. | 10.78B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -236.33M |
| Revenue (Quarterly) | 225.30M |
| Total Expenses (Quarterly) | 461.63M |
| EPS Diluted (Quarterly) | -2.640 |
| Gross Profit Margin (Quarterly) | 93.33% |
| Profit Margin (Quarterly) | -104.9% |
| Earnings Yield | -2.12% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 3.119 |